Stock Screener App

Frei -

Installieren

149.75

0.30% -0.45

after-market

Handel nachbörslich: 149.75

Krystal Biotech Inc (KRYS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt KRYS? Forum Prognose

Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.91% 96.04	88.18	83.84	70.28	45.25
Operating Expenses	9.09% 56.73	52.01	61.41	61.72	51.93
Benefits Costs and Expenses	10.50% 49.27	44.59	54.07	54.24	-
Costs And Expenses	10.50% 49.27	44.59	54.07	54.24	51.93
Operating Income/Loss	8.65% 39.31	36.18	22.43	8.566	-6.684
Income/Loss From Continuing Operations Before Tax	7.29% 46.77	43.60	29.77	16.05	0.932
Income Tax Expense/Benefit	7.35% 8.442	7.864	2.589	0.477	-
Income/Loss From Continuing Operations After Tax	7.28% 38.33	35.73	27.18	15.57	0.932
Net Income/Loss	7.28% 38.33	35.73	27.18	15.57	0.932
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.33% 28.91	28.82	28.72	28.60	28.30
Diluted Average Shares	0.41% 29.75	29.87	29.90	29.64	29.29
Basic Earnings Per Share	7.26% 1.33	1.24	0.95	0.54	0.03
Diluted Earnings Per Share	7.50% 1.29	1.20	0.91	0.53	0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$85.44

1.75%

GMAB

$27.38

1.11%

SMMT

$23.80

1.19%

BNTX

$103.50

3.07%

INSM

$142.53

0.68%

ONC

$318.73

5.21%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters